J Breast Cancer.  2007 Jun;10(2):153-156. 10.4048/jbc.2007.10.2.153.

Methylene Blue for Localization of Sentinel Lymph Nodes in Breast Cancer: A Comparison with Isosulfan Blue

• Lee S
• Kim JA
• Yu KE
• Choi YJ
• Kim JH
• Nam SJ
• Yang JH

• KMID: 1745059
• DOI: http://doi.org/10.4048/jbc.2007.10.2.153

Abstract

PURPOSE: Isosulfan blue dye has been widely used for localizing sentinel lymph nodes (SLNs) in breast cancer patients. The use of methylene blue has recently been applied for localizing SLNs. We compared the use of each dye to investigate the effectiveness of methylene blue for the localization of SLNs.
METHODS
From January to December of 2005, 326 patients underwent surgery for breast cancer at Samsung Medical Center. In 86 patients, only a blue dye was used for SLN localization. Isosulfan blue and methylene blue were randomly given. Each dye (5 mL) was given by subareolar or peritumoral injection. The injection site was gently massaged with a warm gauze for 5 min. A frozen biopsy was performed for all SLNs, and an axillary dissection was done for positive frozen biopsy cases or cases in which axillary metastasis was clinically suspected.
RESULTS
Fifty-eight cases (61.1%) had been treated with isosulfan blue and 37 cases (38.9%) had been treated with methylene blue. Blue nodes were found in 96.6% of samples in the isosulfan blue group and 86.5% of samples in the methylene blue group. The mean number of SLNs was 2.10 in the isosulfan blue group and 2.27 in the methylene blue group (p>0.05). The frozen biopsy was positive for malignant cells in 16 of 56 cases in the isosulfan blue group and 4 of 32 cases in the methylene blue group. Axillary lymph node dissection was performed in 23 cases in the isosulfan blue group and 19 cases in the methylene blue group.
CONCLUSION
There are no significant differences in the success rate, the mean number of SLNs found and the false negative rate between the use of isosulfan blue and methylene blue for localization of SLNs in breast cancer patients.

Keyword

Methylene blue; Isosulfan blue; Breast cancer; Sentinel lymph node biopsy

MeSH Terms

Biopsy
Breast Neoplasms*
Breast*
Humans
Lymph Node Excision
Lymph Nodes*
Methylene Blue*
Neoplasm Metastasis
Sentinel Lymph Node Biopsy
Methylene Blue

Reference

1. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997. 15:2345–2350.

2. O'Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg. 1998. 186:423–427.

3. Chadwick BL, Hunter ML, Evans MT, Hunter B. Allergic reaction to the food dye patent blue. Br Dent J. 1990. 168:386–387.

4. Link EM, Costa DC, Lane D, Blower PJ, Spittle MF. Radioiodinated methylene blue for diagnosing early melanoma metastases. Lancet. 1996. 348:753.

5. Evora PR, Roselino CH, Schiaveto PM. Methylene blue in anaphylactic shock. Ann Emerg Med. 1997. 30:240.

6. Preiser JC, Lejeune P, Roman A, Carlier E, De Backer D, Leeman M, et al. Methylene blue administration in septic shock: a clinical trial. Crit Care Med. 1995. 23:259–264.

7. Simmons RM, Smith SM, Osborne MP. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Breast J. 2001. 7:181–183.

8. Bass SS, Cox CE, Ku NN, Berman C, Reintgen DS. The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg. 1999. 189:183–194.

9. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994. 220:391–398.

10. Blessing WD, Stolier AJ, Teng SC, Bolton JS, Fuhrman GM. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg. 2002. 184:341–345.

11. Cimmino VM, Brown AC, Szocik JF, Pass HA, Moline S, De SK, et al. Allergic reactions to isosulfan blue during sentinel node biopsy--a common event. Surgery. 2001. 130:439–442.

12. Lyew MA, Gamblin TC, Ayoub M. Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. Anesthesiology. 2000. 93:1145–1146.

13. Cox CE, Salud CJ, Harrinton MA. The role of selective sentinel lymph node dissection in breast cancer. Surg Clin North Am. 2000. 80:1759–1777.

14. Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg. 2002. 184:350–352.